|
US5962527A
(en)
*
|
1995-03-21 |
1999-10-05 |
The Board Of Trustees Of The University Of Illinois |
Method and composition for treating cancers
|
|
US5658947A
(en)
*
|
1995-03-21 |
1997-08-19 |
Board Of Trustees Of The University Of Illinois |
Method and composition for selectively inhibiting melanoma using betalinic acid
|
|
US5869535A
(en)
|
1995-03-21 |
1999-02-09 |
The Board Of Trustees Of The University Of Illinois |
Method and composition for selectively inhibiting melanoma
|
|
US5679828A
(en)
*
|
1995-06-05 |
1997-10-21 |
Biotech Research Labs, Inc. |
Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
|
|
WO1998055497A1
(en)
|
1997-06-04 |
1998-12-10 |
Cornell Research Foundation, Inc. |
Betulinol derivatives
|
|
US6403816B1
(en)
*
|
1997-09-30 |
2002-06-11 |
Dabur Research Foundation |
Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
|
|
PT1068219E
(pt)
*
|
1998-03-02 |
2007-03-30 |
Univ North Carolina |
Derivados acilados de betulina e de di-hidrobetulina, sua preparação e sua utilização
|
|
US6369101B1
(en)
|
1999-02-26 |
2002-04-09 |
Regents Of The University Of Minnesota |
Therapeutic method to treat herpes virus infection
|
|
US6392070B1
(en)
|
1999-08-10 |
2002-05-21 |
Regents Of The University Of Minnesota |
Birch bark processing and the isolation of natural products from birch bark
|
|
KR100618100B1
(ko)
*
|
1999-09-09 |
2006-08-29 |
다브르 리서치 파운데이션 |
항맥관형성 활성을 가지는 새로운 베툴린산 유도체,이러한 유도체의 제조 방법 및 종양 관련 맥관형성증의치료를 위한 이들의 용도
|
|
CA2418479C
(en)
|
2000-08-18 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Prodrugs of betulinic acid derivatives for the treatment of cancer
|
|
WO2002091858A1
(en)
*
|
2001-05-11 |
2002-11-21 |
University Of Ottawa |
Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
|
|
GB0128071D0
(en)
*
|
2001-11-22 |
2002-01-16 |
Cyclacel Ltd |
Medicament
|
|
RU2211843C1
(ru)
*
|
2002-01-25 |
2003-09-10 |
Новосибирский институт органической химии им. Н.Н.Ворожцова СО РАН |
N'-{n-[3-оксо-20(29)-лупен-28-оил]-9-аминононаноил}-3-амино-3-фенилпропио новая кислота, обладающая иммуностимулирующей и противовирусной активностью
|
|
US7537765B2
(en)
*
|
2003-01-29 |
2009-05-26 |
Panacos Pharmaceuticals, Inc. |
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
|
|
JP2006520756A
(ja)
*
|
2003-01-29 |
2006-09-14 |
パナコス ファーマシューティカルズ インコーポレーティッド |
ウイルスキャプシドスペーサーペプチド１タンパク質のプロセシングの破壊によるｈｉｖ−１複製の阻害
|
|
US7026305B2
(en)
*
|
2003-04-14 |
2006-04-11 |
Meharry Medical College |
Anti-HIV agents with dual sites of action
|
|
US7326717B2
(en)
*
|
2003-05-06 |
2008-02-05 |
L'oreal |
Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
|
|
MXPA06010592A
(es)
*
|
2004-03-17 |
2007-06-12 |
Panacos Pharmaceuticals Inc |
Sales farmaceuticas de acido 3-o-(3',3'-dimetilsuccinil) betulinico.
|
|
WO2005112929A2
(en)
*
|
2004-05-20 |
2005-12-01 |
Cornell Research Foundation, Inc. |
Anti-hiv-1 activity of betulinol derivatives
|
|
US7282521B2
(en)
*
|
2004-05-24 |
2007-10-16 |
University Of North Carolina At Chapel Hill |
Anti-retroviral moronic acid derivatives
|
|
CA2607177A1
(en)
*
|
2004-09-10 |
2006-03-23 |
Brij B. Saxena |
Betulinol derivatives as anti-cancer agents
|
|
TW200628161A
(en)
*
|
2004-11-12 |
2006-08-16 |
Panacos Pharmaceuticals Inc |
Novel betulin derivatives, preparation thereof and use thereof
|
|
US20060193804A1
(en)
*
|
2005-02-24 |
2006-08-31 |
L'oreal |
Haircare use of cyclic amine derivatives
|
|
JP2008535923A
(ja)
|
2005-04-12 |
2008-09-04 |
パナコス ファーマシューティカルズ インコーポレーティッド |
３−ｏ−（３’，３’−ジメチルスクシニル）ベツリン酸ジ−ｎ−メチル−ｄ−グルカミンの多形
|
|
US20090149429A1
(en)
*
|
2005-06-22 |
2009-06-11 |
Myriad Genetics, Incorporated |
Antiviral compounds
|
|
US20070197646A1
(en)
*
|
2006-02-21 |
2007-08-23 |
Achillion Pharmaceuticals, Inc. |
Substituted taraxastanes useful for treating viral infections
|
|
US20080039428A1
(en)
*
|
2006-06-29 |
2008-02-14 |
Panacos Pharmaceuticals, Inc. |
Antiretroviral combination therapy
|
|
US20110144069A1
(en)
*
|
2006-10-16 |
2011-06-16 |
Myriad Genetics, Incorporated |
Compounds for treating viral infections
|
|
RU2317996C1
(ru)
*
|
2006-10-30 |
2008-02-27 |
Институт нефтехимии и катализа РАН |
N'-{n-[3-оксо-лупан-28-оил]-9-аминононаноил}-3-амино-3-фенил-пропионовая кислота и ее соли как противовирусные и иммуностимулирующие агенты
|
|
WO2009020732A1
(en)
*
|
2007-08-03 |
2009-02-12 |
Advanced Life Sciences, Inc. |
Lupane-type triterpenoids modified at 30-position and analogues thereof
|
|
FR2920309B1
(fr)
|
2007-08-28 |
2010-05-28 |
Galderma Res & Dev |
Utilisation de travoprost pour traiter la chute des cheveux
|
|
RU2353623C1
(ru)
*
|
2007-09-17 |
2009-04-27 |
Новосибирский институт органической химии им. Н.Н. Ворожцова СО РАН (НИОХ СО РАН) |
Корректор цитостатической полихимиотерапии
|
|
RU2357973C1
(ru)
*
|
2007-09-26 |
2009-06-10 |
ИНСТИТУТ НЕФТЕХИМИИ И КАТАЛИЗА Российской Академии Наук |
Способ получения дипептидов лупанового ряда
|
|
WO2009090063A1
(en)
*
|
2008-01-16 |
2009-07-23 |
Jado Technologies Gmbh |
Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases
|
|
FR2929118B1
(fr)
|
2008-03-28 |
2010-05-07 |
Oreal |
Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
|
|
FR2929117B1
(fr)
|
2008-03-28 |
2010-05-07 |
Oreal |
Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
|
|
KR100941595B1
(ko)
*
|
2008-06-05 |
2010-02-11 |
주식회사 알앤엘바이오 |
바이러스 억제제로서 유용한 트리테르페노이드계 화합물
|
|
RU2385324C1
(ru)
*
|
2008-07-07 |
2010-03-27 |
Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) (статус государственного учреждения) |
Корректор паранеопластических повреждений и токсических эффектов цитостатической полихимиотерапии
|
|
FR2949052B1
(fr)
|
2009-08-13 |
2015-03-27 |
Oreal |
Procede de traitement cosmetique du cuir chevelu.
|
|
CN102558280B
(zh)
*
|
2011-11-18 |
2014-09-17 |
温州大学 |
一种30-卤代桦木酸的生产方法
|
|
EP3295940A1
(en)
|
2012-04-16 |
2018-03-21 |
Case Western Reserve University |
Compositions and methods of modulating 15-pgdh activity
|
|
SG11201505639SA
(en)
*
|
2013-02-06 |
2015-08-28 |
Bristol Myers Squibb Co |
C-19 modified triterpenoids with hiv maturation inhibitory activity
|
|
US9789116B2
(en)
|
2013-10-15 |
2017-10-17 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
CN104045680B
(zh)
|
2014-06-20 |
2016-09-14 |
东北林业大学 |
桦木醇的乙酰氨基酸酰类衍生物及其制备方法
|
|
EP3226859B1
(en)
|
2014-12-05 |
2025-03-26 |
Case Western Reserve University |
Akr1a1 inhibitors for use in lowering cholesterol and modulate s-nitrosylation
|
|
PL227790B1
(pl)
|
2015-08-13 |
2018-01-31 |
Slaski Univ Medyczny W Katowicach |
Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie.
|
|
US10688037B1
(en)
|
2015-12-31 |
2020-06-23 |
Nutraceutical Wellness Inc. |
Compositions and method for hair regrowth
|
|
WO2018102552A1
(en)
|
2016-11-30 |
2018-06-07 |
Case Western Reserve University |
Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof
|
|
JP2020514323A
(ja)
|
2017-02-06 |
2020-05-21 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物と方法
|
|
PL237998B1
(pl)
|
2018-05-28 |
2021-06-28 |
Narodowy Inst Lekow |
Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie
|
|
EA202191422A1
(ru)
|
2018-11-21 |
2021-10-21 |
Кейс Вестерн Ризерв Юниверсити |
Композиции и способы модулирования активности короткоцепочечной дегидрогеназы
|
|
AU2021275122A1
(en)
|
2020-05-20 |
2022-12-15 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|